Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 24572077

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Apr
First author
Hoskin PJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Apr;15(4):372-4. doi: 10.1016/S1470-2045(14)70070-1.
    note
    Source null
    related pmid
    24572076
    relationship
    Comment in
  2. citation
    Strahlenther Onkol. 2014 Oct;190(11):1084-5. doi: 10.1007/s00066-014-0728-8.
    note
    Source null
    related pmid
    25538992
    relationship
    Comment in

Authors and identifiers

  1. name
    Hoskin PJ
    type
    Author
  2. name
    Kirkwood AA
    type
    Author
  3. name
    Popova B
    type
    Author
  4. name
    Smith P
    type
    Author
  5. name
    Robinson M
    type
    Author
  6. name
    Gallop-Evans E
    type
    Author
  7. name
    Coltart S
    type
    Author
  8. name
    Illidge T
    type
    Author
  9. name
    Madhavan K
    type
    Author
  10. name
    Brammer C
    type
    Author
  11. name
    Diez P
    type
    Author
  12. name
    Jack A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hoskin PJ
    type
    Author
  2. name
    Kirkwood AA
    type
    Author
  3. name
    Popova B
    type
    Author
  4. name
    Smith P
    type
    Author
  5. name
    Robinson M
    type
    Author
  6. name
    Gallop-Evans E
    type
    Author
  7. name
    Coltart S
    type
    Author
  8. name
    Illidge T
    type
    Author
  9. name
    Madhavan K
    type
    Author
  10. name
    Brammer C
    type
    Author
  11. name
    Diez P
    type
    Author
  12. name
    Jack A
    type
    Author
bibliography ids
  1. nci-bib-488c6034469c488f323dd523
book metadata
content sha256
15205a46d1019c82e0bd9d119d9f7549d319bab481c3909bab4a39852251b4f1
document type
citation
dois
  1. 10.1016/S1470-2045(14)70036-1
electronic publication date
display
2014 Feb 24
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24572077
immutable id
pubmed:24572077@15205a46d1019c82e0bd9d119d9f7549d319bab481c3909bab4a39852251b4f1
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
457-63
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Apr;15(4):372-4. doi: 10.1016/S1470-2045(14)70070-1.
    note
    Source null
    related pmid
    24572076
    relationship
    Comment in
  2. citation
    Strahlenther Onkol. 2014 Oct;190(11):1084-5. doi: 10.1007/s00066-014-0728-8.
    note
    Source null
    related pmid
    25538992
    relationship
    Comment in
outcomes validated
false
pmid
24572077
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
15866aca49770080cd1055cad81500e6a4b24bf2a06f0fa988ea4839b507b106
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Apr
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24572077/
title
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.

Preserved source evidence · Independent clinical review pending · Not medical advice